SCUBE2 and breast carcinoma: In addition, the study showed that EGCG inhibits breast cancer cell viability and suppresses the migration and invasion capacities of the cells, while knockdown of endogenous SCUBE2 blocks these inhibitory effects of EGCG in breast cancer cells.